| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |